Search

Your search keyword '"Scholte op Reimer, Wilma"' showing total 441 results
Start Over Author "Scholte op Reimer, Wilma"
441 results on '"Scholte op Reimer, Wilma"'

3. Modifiable risk factors and motivation for lifestyle change of CVD patients starting cardiac rehabilitation: The BENEFIT study

Author

Breeman, Linda D., Pérez-Alonso, Andrés, Kühling-Romero, David, Kraaijenhagen, Roderik A., Al-Dhahir, Isra, IJzerman, Renée V.H., van Eersel, Roxy, Wolstencroft, Katherine, Bonten, Tobias N., Atsma, Douwe E., Chavannes, Niels H., van Gemert-Pijnen, Lisette, Kemps, Hareld M.C., Scholte op Reimer, Wilma, Evers, Andrea W.M., and Janssen, Veronica R.

Published
2025
Full Text
View/download PDF

9. Home-based cardiac rehabilitation in older adults: expert-recommendations for physiotherapist-led care to improve daily physical functioning and reduce comorbidity-related barriers.

Author

Terbraak, Michel, Major, Mel, Jørstad, Harald, Scholte op Reimer, Wilma, and van der Schaaf, Marike

Subjects
WORK, CONSENSUS (Social sciences), RESEARCH funding, FRAIL elderly, FUNCTIONAL status, DESCRIPTIVE statistics, QUALITY of life, HOME rehabilitation, DELPHI method, CARDIAC rehabilitation, COMORBIDITY, EXPERIENTIAL learning, PATIENTS' attitudes, OLD age
Abstract

Background: Cardiac rehabilitation (CR) can reduce mortality and improve physical functioning in older patients, but current programs do not support the needs of older patients with comorbidities or frailty, for example due to transport problems and physical limitations. Home-exercise-based cardiac rehabilitation (HEBCR) programs may better meet these needs, but physiotherapy guidelines for personalising HEBCR for older, frail patients with cardiovascular disease are lacking. Purpose: To provide expert recommendations for physiotherapists on how to administer HEBCR to older adults with comorbidities or frailty. Methods: This Delphi study involved a panel of Dutch experts in physiotherapy, exercise physiology, and cardiology. Three Delphi rounds were conducted between December 2020 and February 2022. In the first round panellists provided expertise on applicability and adaptability of existing CR-guidelines. In the second round panellists ranked the importance of statements about HEBCR for older adults. In the third round panellists re-ranked statements when individual scores were outside the semi-interquartile range. Consensus was defined as a semi-interquartile range of ≤ 1.0. Results: Of 20 invited panellists, 11 (55%) participated. Panellists were clinical experts with a median (interquartile range) work experience of 20 (10.5) years. The panel reached a consensus on 89% of statements, identifying key topics such as implementing the patient perspective, assessing comorbidity and frailty barriers to exercise, and focusing on personal goals and preferences. Conclusion: This Delphi study provides recommendations for personalised HEBCR for older, frail patients with cardiovascular disease, which can improve the effectiveness of CR-programs and address the needs of this patient population. Prioritising interventions aimed at enhancing balance, lower extremity strength, and daily activities over interventions targeting exercise capacity may contribute to a more holistic and effective approach, particularly for older adults. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

14. Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort

Author

Interne Geneeskunde Vasculaire, Circulatory Health, MS Interne Geneeskunde, Van Trier, Tinka J., Snaterse, Marjolein, Boekholdt, S. Matthijs, Scholte Op Reimer, Wilma J.M., Hageman, Steven H.J., Visseren, Frank L.J., Dorresteijn, Jannick A.N., Peters, Ron J.G., Jørstad, Harald T., Interne Geneeskunde Vasculaire, Circulatory Health, MS Interne Geneeskunde, Van Trier, Tinka J., Snaterse, Marjolein, Boekholdt, S. Matthijs, Scholte Op Reimer, Wilma J.M., Hageman, Steven H.J., Visseren, Frank L.J., Dorresteijn, Jannick A.N., Peters, Ron J.G., and Jørstad, Harald T.

Published
2024

15. Patients' preferences for secondary prevention following a coronary event

Author

van Trier, Tinka J., Jørstad, Harald T., Scholte op Reimer, Wilma J.M., Sunamura, Madoka, ter Hoeve, Nienke, Aernout Somsen, G., Peters, Ron J.G., Snaterse, Marjolein, van Trier, Tinka J., Jørstad, Harald T., Scholte op Reimer, Wilma J.M., Sunamura, Madoka, ter Hoeve, Nienke, Aernout Somsen, G., Peters, Ron J.G., and Snaterse, Marjolein

Abstract

Objective:Despite clear evidence on the effectiveness of secondary prevention, patients with coronary artery disease frequently fail to reach guideline-based risk factor targets. Integrating patients’ preferences into treatment decisions has been recommended to reduce this gap. However, this requires knowledge about patient treatment preferences. Therefore, through a survey study, we aimed to explore which risk factors patients self-perceived, prioritised for improvement, and needed support with after a recent hospitalisation for coronary heart disease. Methods: A digital questionnaire was presented to patients > 18 years recently discharged (≤3 months) from an acute coronary care unit in the Netherlands (Europe). Patients could select from eight cardiovascular risk factors that they (1) self-perceived, (2) prioritised for improvement, and (3) needed support to improve. Patients’ perceived risk factors were compared to those documented in the medical records. Results: Respondents (N = 254, 26 % women), mean age 64 (SD 10) years, identified ‘physical inactivity’ more frequently than their medical records (140 patients vs. 91 records, p < 0.001), while three other risk factors were reported with equal and four with lower frequency. ‘Physical inactivity’, ‘overweight’ and ‘stress’ were most frequently prioritised for improvement (82 %, 88 % and 78 %) and professional support (64 %, 50 % and 58 %), with 87 % preferring lifestyle optimisation if this would reduce drug use. Conclusions: Patients with a recent coronary event show significant disparities in identifying risk factors compared to their medical records. They tend to prefer improving lifestyle- over drug-modifiable risk factors, particularly physical inactivity, overweight and stress, and indicate the need for support in improving these factors.

Published
2024

32. Unexploited potential of risk factor treatment in patients with atherosclerotic cardiovascular disease

Author

van Trier, Tinka J., Snaterse, Marjolein, Hageman, Steven H.J., Ter Hoeve, Nienke, Sunamura, Madoka, Moll van Charante, Eric P., Galenkamp, Henrike, Deckers, Jaap W., Martens, Fabrice M.A.C., Visseren, Frank L.J., Scholte Op Reimer, Wilma J.M., Peters, Ron J.G., Jørstad, Harald T., van Trier, Tinka J., Snaterse, Marjolein, Hageman, Steven H.J., Ter Hoeve, Nienke, Sunamura, Madoka, Moll van Charante, Eric P., Galenkamp, Henrike, Deckers, Jaap W., Martens, Fabrice M.A.C., Visseren, Frank L.J., Scholte Op Reimer, Wilma J.M., Peters, Ron J.G., and Jørstad, Harald T.

Abstract

BACKGROUND: Most patients with atherosclerotic cardiovascular disease remain at (very) high risk for recurrent events due to suboptimal risk factor control. AIMS: This study aimed to quantify the potential of maximal risk factor treatment on 10-year and lifetime risk of recurrent atherosclerotic cardiovascular events in patients 1 year after a coronary event. METHODS AND RESULTS: Pooled data from six studies are as follows: RESPONSE 1, RESPONSE 2, OPTICARE, EUROASPIRE IV, EUROASPIRE V, and HELIUS. Patients aged ≥45 years at ≥6 months after coronary event were included. The SMART-REACH score was used to estimate 10-year and lifetime risk of recurrent atherosclerotic cardiovascular events with current treatment and potential risk reduction and gains in event-free years with maximal treatment (lifestyle and pharmacological). In 3230 atherosclerotic cardiovascular disease patients (24% women), at median interquartile range (IQR) 1.1 years (1.0-1.8) after index event, 10-year risk was median (IQR) 20% (15-27%) and lifetime risk 54% (47-63%). Whereas 70% used conventional medication, 82% had ≥1 drug-modifiable risk factor not on target. Furthermore, 91% had ≥1 lifestyle-related risk factor not on target. Maximizing therapy was associated with a potential reduction of median (IQR) 10-year risk to 6% (4-8%) and of lifetime risk to 20% (15-27%) and a median (IQR) gain of 7.3 (5.4-10.4) atherosclerotic cardiovascular disease event-free years. CONCLUSIONS: Amongst patients with atherosclerotic cardiovascular disease, maximizing current, guideline-based preventive therapy has the potential to mitigate a large part of their risk of recurrent events and to add a clinically important number of event-free years to their lifetime.

Published
2023

33. Unexploited potential of risk factor treatment in patients with atherosclerotic cardiovascular disease

Author

Interne Geneeskunde Vasculaire, Circulatory Health, van Trier, Tinka J., Snaterse, Marjolein, Hageman, Steven H.J., Ter Hoeve, Nienke, Sunamura, Madoka, Moll van Charante, Eric P., Galenkamp, Henrike, Deckers, Jaap W., Martens, Fabrice M.A.C., Visseren, Frank L.J., Scholte Op Reimer, Wilma J.M., Peters, Ron J.G., Jørstad, Harald T., Interne Geneeskunde Vasculaire, Circulatory Health, van Trier, Tinka J., Snaterse, Marjolein, Hageman, Steven H.J., Ter Hoeve, Nienke, Sunamura, Madoka, Moll van Charante, Eric P., Galenkamp, Henrike, Deckers, Jaap W., Martens, Fabrice M.A.C., Visseren, Frank L.J., Scholte Op Reimer, Wilma J.M., Peters, Ron J.G., and Jørstad, Harald T.

Published
2023

35. Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort

Author

van Trier, Tinka J, Snaterse, Marjolein, Boekholdt, S Matthijs, Scholte op Reimer, Wilma J M, Hageman, Steven H J, Visseren, Frank L J, Dorresteijn, Jannick A N, Peters, Ron J G, and Jørstad, Harald T

Abstract

To effectively prevent heart disease, it is important to identify individuals who are at a higher risk of developing it. Researchers have developed models that can estimate the likelihood of a healthy person developing heart disease within the next 10 years. This study, involving 22 673 healthy individuals in the UK, aimed to determine if these risk estimation models are accurate and can guide decisions about who should receive preventive treatment.

Published
2024
Full Text
View/download PDF

38. Unexploited potential of risk factor treatment in patients with atherosclerotic cardiovascular disease

Author

van Trier, Tinka J, primary, Snaterse, Marjolein, additional, Hageman, Steven H J, additional, ter Hoeve, Nienke, additional, Sunamura, Madoka, additional, Moll van Charante, Eric P, additional, Galenkamp, Henrike, additional, Deckers, Jaap W, additional, Martens, Fabrice M A C, additional, Visseren, Frank L J, additional, Scholte op Reimer, Wilma J M, additional, Peters, Ron J G, additional, and Jørstad, Harald T, additional

Published
2023
Full Text
View/download PDF

43. Additional file 7 of Effects of a shared decision making intervention for older adults with multiple chronic conditions: the DICO study

Author

Pel-Littel, Ruth E., Buurman, Bianca M., van de Pol, Marjolein H., Twisk, Jos W. R., Tulner, Linda R., Minkman, Mirella M., Scholte op Reimer, Wilma J. M., and van Weert, Julia C. M.

Abstract

Additional file 7. Observer OPTIONMCC scores for geriatricians, patients and informal caregivers (subgroup analysis of eight geriatricians).

Published
2023
Full Text
View/download PDF

49. Preprocedural muscle strength and physical performance and the association with functional decline or mortality in frail older patients after transcatheter aortic valve implementation: a systematic review and meta-analysis

Author

van Erck, Dennis, primary, Dolman, Christine D, additional, Limpens, Jacqueline, additional, Scholte op Reimer, Wilma J M, additional, Henriques, José P, additional, Delewi, Ronak, additional, and Schoufour, Josje D, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results